Medical Marijuana Inc’s Dixie Elixir and Edibles Brand to Launch First non-THC Based Line of Health and Wellness Products
Colorado’s Leading Manufacturer of Edible Medical Marijuana Products Expands Patient Footprint with Federally Legal Hemp Extract (Cannabidiol) Products to Address Pain Relief, Mental Focus and Sleep Regularity
DENVER, CO -- MAY 2, 2012 -- Dixie Elixirs and Edibles, Colorado’s premier Tetrahydrocannabinol or THC-infused products company, today announced a new line of products which will break entirely new ground for the company in the category of non THC-infused product development. Following closely on the heels of its’ acquisition by cannabis and hemp industry innovators, Medical Marijuana, Inc. (OTC: MJNA), today’s announcement consists of three new hemp-based Cannabidiol (CBD) products that contain no THC:
DixieDewDrops: a sublingual glycerin-based tincture designed for pain reliefDixieBotanicals: a topical pain relief salve and massage oilDixieScrips: a pharmaceutical grade CBD capsule in two varieties; one for daytime focus/mental energy and the other a night time sleep aid.The Food and Drug Administration (FDA) currently considers hemp based cannabinoids, including CBD, to be “food based” and therefore legal without a medical marijuana license. Amongst the many potential uses for CBD-based products that are currently under evaluation, CBD’s have been shown to relieve convulsion, inflammation, anxiety, and nausea. Based on medical potential and the federally legal status of hemp-based CBD products, Dixie and Medical Marijuana, Inc., estimate the market in the U. S. to be well over $5 billion. These three new products are the first of many that the companies intend to bring to the market in the coming year.
Dixie will initially offer the new products exclusively to their existing customer base which consists of over 400 dispensaries in the state of Colorado. This consumer base represents in excess of 70 percent of the addressable medical marijuana market inColoradoand over nine percent of theU. S.medical cannabis market. Within 90 days the Company intends to launch a mail order campaign and online e-commerce platform that will allow individuals throughout the U. S. to purchase these products since they contain no THC. TheU. S.availability will be followed closely by distribution in international markets includingEuropevia several key product distribution relationships that are currently under negotiation.
“From the day that we created our first medicated elixirs, we have known that as an industry we have only just begun to tap the very deep health and healing properties of cannabis,” said Tripp Keber, President and CEO of Dixie Elixirs and Red Dice Holdings, LLC. “These three new products open up a world of potential for Dixieand Medical Marijuana, Inc. to bring healthy alternatives to millions of patients who might otherwise never experience the tremendous benefits of cannabinoids. This is truly an exciting development for Dixie and we look forward to bringing Dixie Scrips, Dixie DewDrops, and Dixie Botanicals to patients around the country and around the world who are looking for a healthful alternative to mass-produced, man-made pharmaceutical products.”
I'm very excited about this because cannabidiol is relieving spasticity/spasms of people with CNS disorders (Sativex) and these products will be available by August, probably earlier. We evolved with an endocannabinoid regulatory system and have lots of cannabinoid receptors on our spinal cords, brains and elsewhere. This is a natural solution I feel confident will help my moderate spasticity...